Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications

BACKGROUND. MGMT methylation status represents a powerful prognostic factor in newly diagnosed glioblastoma (GBM). Recently, its role in recurrent tumors has also been suggested; however, few data investigating the stability of this biomarker during the clinical course of the disease are available....

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncologist
मुख्य लेखकों: Brandes, Alba A., Franceschi, Enrico, Paccapelo, Alexandro, Tallini, Giovanni, De Biase, Dario, Ghimenton, Claudio, Danieli, Daniela, Zunarelli, Elena, Lanza, Giovanni, Silini, Enrico Maria, Sturiale, Carmelo, Volpin, Lorenzo, Servadei, Franco, Talacchi, Andrea, Fioravanti, Antonio, Pia Foschini, Maria, Bartolini, Stefania, Pession, Annalisa, Ermani, Mario
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: AlphaMed Press 2017
विषय:
Neuro‐Oncology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5388380/
https://ncbi.nlm.nih.gov/pubmed/28275120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0254
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन